TEVATeva Pharmaceutical Industries Limited

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · tevapharm.com

37.34USDMkt Cap: 43.51B $P/E: 62.233d ago

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers gen…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

HIK

Hikma Pharmaceuticals PLC

$4.35BUSDP/E 12.7

Key Statistics

Company

Market Cap43.51B $

Enterprise Value56.14B $

Revenue (TTM)17.32B $

Gross Profit8.94B $

Net Income (TTM)1.41B $

Revenue/Share15.00 USD

Last Price37.34 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees31.2K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)62.23

P/E (Forward)11.97

PEG1.03

EV/EBITDA13.15

EV/Revenue3.24

P/S2.48

P/B5.53

EPS (TTM)0.59

EPS (Forward)3.08

52W Range

36.6563% of range37.75

52W High37.75 USD

52W Low36.65 USD

Profitability

Gross Margin51.79%

Oper. Margin4.03%

EBITDA Margin24.65%

Profit Margin8.17%

ROE17.83%

ROA3.46%

Growth

Revenue Growth-0.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.65B $

CapEx (TTM)501.00M $

FCF Margin12.82%

FCF Yield5.10%

Net Debt13.24B $

Net Debt/EBITDA3.10

Balance Sheet

Debt/Equity2.16

Current Ratio0.88

Quick Ratio0.46

Book Value/Sh6.653 USD

Cash/Share3.137 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield2.95%

Payout Ratio0.00%

Ex-Div DateNov 27, 2017

Pay DateDec 12, 2017

Splits

Last Split2:1

Split DateJul 1, 2004

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)41.40 USD

Upside (mean)+10.9%

Target Range33.00 USD – 50.00 USD

$33.00+10.9% to mean$50.00

# Analysts10

Ownership

Shares Out.1.17B

Float1.09B

Insiders0.00%

Institutions64.53%

Short Interest

Short Ratio6.2d

Short % Float2.96%

Short % Out.2.95%

Shares Short34.32M

Short (prev mo.)32.03M

Technical

SMA 5033.76 (+10.6%)

SMA 20031.78 (+17.5%)

Beta0.88

S&P 52W Chg21.00%

Avg Vol (30d)2.80M

Avg Vol (10d)5.55M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—